Heracles Leadership Team

Professor Suks Minhas

Co-Founder & Chief Medical Officer

GMC ref no: 3334887

About

Professor Suks Minhas is a Consultant Urologist and Andrologist based in London, and Co-Founder and Chief Medical Officer at Heracles. He is Director of the European Academy of Andrology and lead author of the EAU Guidelines on Male Sexual and Reproductive Health.

Suks has published more than 250 papers and delivered over 600 international lectures, helping shape global clinical guidelines and surgical practice in andrology. He is a recipient of the St Peter's Medal and the BAUS Golden Telescope Award for his contribution to British urology.

At Heracles, Suks is the primary clinical voice behind our approach to TRT, low testosterone, and men's hormonal health - combining the latest research with a commitment to accessible, evidence-based care.

Medical expertise

Professor Minhas specialises in men's hormonal and reproductive health, with particular expertise in:

  • Low testosterone and TRT
  • Male fertility and andrology
  • Hormonal health guidelines and clinical standards
  • Andrological surgery
  • Evidence-based, personalised care for men

He provides expert guidance on testosterone therapy, helping men understand their options and access treatment built around long-term health.

Registered

GMC ref no: 3334887

Qualifications

MD FRCS (Urol)
Consultant Urologist and Andrologist
Director, European Academy of Andrology
Lead author, EAU Guidelines on Male Sexual and Reproductive Health

Publications and Achievements

Minhas S, Boeri L, Capogrosso P, et al. European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2025 Update on Male Infertility. Eur Urol. 2025 May;87(5):601-616.

Minhas S, Bettocchi C, Boeri L, et al. European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2021 Update on Male Infertility. Eur Urol. 2021 Nov;80(5):603-620.

Minhas S, et al. Frequency, morbidity and equity - the case for increased research on male fertility. Nat Rev Urol. 2023.

Learn about TRT

No items found.